NeuroPace Inc
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
NPCE$13.12+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets
| March 31, | December 31, | |
|---|---|---|
| (in thousands, except share and per share amounts) | 2025 | 2024 |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $27,019 | $13,430 |
| Short-term investments | 39,243 | 39,325 |
| Accounts receivable | 15,435 | 12,851 |
| Inventory | 13,580 | 13,381 |
| Prepaid expenses and other current assets | 2,201 | 2,352 |
| Total current assets | 97,478 | 81,339 |
| Property and equipment, net | 1,160 | 1,052 |
| Operating lease right-of-use asset | 11,430 | 11,843 |
| Restricted cash | 122 | 122 |
| Deferred offering costs | — | 276 |
| Other assets | 15 | 15 |
| Total assets | $110,205 | $94,647 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $4,046 | $2,954 |
| Accrued liabilities | 8,058 | 9,787 |
| Operating lease liability | 1,923 | 1,860 |
| Deferred revenue | 680 | 555 |
| Total current liabilities | 14,707 | 15,156 |
| Long-term debt | 59,788 | 59,525 |
| Operating lease liability, net of current portion | 11,441 | 11,953 |
| Total liabilities | 85,936 | 86,634 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized and no shares issued and outstanding as of March 31, 2025 and December 31, 2024 | — | — |
| Common stock, $0.001 par value, 200,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 32,751,240 and 30,145,039 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 33 | 30 |
| Additional paid-in capital | 561,775 | 538,933 |
| Accumulated deficit | (537,539) | (530,950) |
| Total stockholders’ equity | 24,269 | 8,013 |
| Total liabilities and stockholders’ equity | $110,205 | $94,647 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.